top of page

Day 98 Oxford and Astrazeneca

Astrazeneca, the British – Swedish drug maker, has joined forces with the UK government to support the Oxford University to develop a coronavirus vaccine. The partnership is one the most closely watched vaccine efforts.

AstraZeneca has signed agreements with governments around the world to supply the vaccine should it prove effective and gain regulatory approval. It has said it will not seek to profit from the vaccine during the pandemic.

Update! In July, the developers released results saying their vaccines had produced strong immune responses with only minor side effects. The results, published in the British medical journal The Lancet, found the vaccine generated both antibody and T-cell immune responses, which are hoped to be key to stopping an infection.

There is still a long way to go but it looks promising.


Recent Posts

See All

Belgium is conducting a large-scale trial with the plasma of recovered COVID-19 patients. The trial is a collaboration between hospitals in Flanders and is coordinated by UZ (University Hospital) Leuv

Tresorit, a start up from Switzerland, empowers medical professionals and education institutions with a highly secure way to store and share information. COVID-19 has significantly changed and challen

The Bill and Melinda Gates Foundation is committing to help fight the pandemic. Since its creation in 2000, the foundation has spent over $40 billion on global development and public health programs s

bottom of page